Prediction of human microRNA targets.

Computational Biology Center, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Methods in Molecular Biology (Impact Factor: 1.29). 02/2006; 342:101-13. DOI: 10.1385/1-59745-123-1:101
Source: PubMed

ABSTRACT MicroRNAs (miRNAs) are small, nonprotein-coding RNAs that regulate gene expression. Although hundreds of human miRNA genes have been discovered, the functions of most of these are unknown. Computational predictions indicate that miRNAs, which account for at least 1% of human protein-coding genes, regulate protein production for thousands of or possibly all of human genes. We discuss the functions of mammalian miRNAs and the experimental and computational methods used to detect and predict human miRNA target genes. Anticipating their impact on genome-wide discovery of miRNA targets, we describe the various computational tools and web-based resources available to predict miRNA targets.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: IRBIS is a computational pipeline for detecting conserved complementary regions in unaligned orthologous sequences. Unlike other methods, it follows the "first-fold-then-align" principle in which all possible combinations of complementary k-mers are searched for simultaneous conservation. The novel trimming procedure reduces the size of the search space and improves the performance to the point where large-scale analyses of intra- and intermolecular RNA-RNA interactions become possible. In this article, I provide a rigorous description of the method, benchmarking on simulated and real data, and a set of stringent predictions of intramolecular RNA structure in placental mammals, drosophilids, and nematodes. I discuss two particular cases of long-range RNA structures that are likely to have a causal effect on single- and multiple-exon skipping, one in the mammalian gene Dystonin and the other in the insect gene Ca-α1D. In Dystonin, one of the two complementary boxes contains a binding site of Rbfox splicing factor similar to the RNA bridge that was recently described in Enah gene. I also report that snoRNAs and long noncoding RNAs (lncRNAs) have a high capacity of base-pairing to introns of protein-coding genes, suggesting possible involvement of these transcripts in splicing regulation. I also find that conserved sequences that occur equally likely on both strands of DNA (e.g., transcription factor binding sites) contribute strongly to the false-discovery rate and, therefore, would confound every such analysis. IRBIS is an open-source software that is available at∼dmitri/irbis.
    RNA 08/2014; 20(10). DOI:10.1261/rna.045088.114 · 4.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: N-Myc Interactor is an inducible protein whose expression is compromised in advanced stage breast cancer. Downregulation of NMI, a gatekeeper of epithelial phenotype, in breast tumors promotes mesenchymal, invasive and metastatic phenotype of the cancer cells. Thus the mechanisms that regulate expression of NMI are of potential interest for understanding the etiology of breast tumor progression and metastasis.
    Molecular Cancer 08/2014; 13(1):200. DOI:10.1186/1476-4598-13-200 · 5.40 Impact Factor
    This article is viewable in ResearchGate's enriched format
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic hepatitis B virus (HBV) infection causes liver disease that can progress to cirrhosis and hepatocellular carcinoma (HCC). Changes in the hepatocyte population that occur from the early immune-tolerant stage of infection to late-stage disease outcomes remain unclear. We hypothesised that some hepatocytes lose HBV antigen expression and escape the HBVspecific immune response, allowing them to undergo clonal proliferation. Clonal proliferation of altered hepatocytes may be a marker of disease progression and may have a direct role in the development of HCC. Liver tissues from 30 patients were analysed, including patients with early-stage HBV infection, late-stage infection with cirrhosis, or with HCC. Unique virus-cell DNA junctions formed by the integration of HBV DNA into the host cell genome were detected using inverse nested PCR (invPCR). The copy number of unique virus-cell DNA junctions was used as a measure of clonal proliferation of hepatocytes. A computer simulation of a liver undergoing stochastic liver turnover was used to determine if the hepatocyte clones observed by invPCR could have been formed by random chance. Immunohistochemistry for HBV surface antigen (HBsAg) expression and Imaging Mass Spectrometry (IMS) for cellular protein expression were carried out to detect cellular changes that may be associated with clonal proliferation. Significantly (p<0.01) larger clones were observed by invPCR in liver DNA extracts of patients with late-stage HBV-associated disease (≤280000 hepatocytes) compared to patients in early-stage HBV infection (8-1124 hepatocytes). Computer simulations indicated that stochastic turnover could not produce clones of >10000 hepatocytes, suggesting that the hepatocytes that had formed large clones had a survival advantage. No significant difference in the extent of clonal proliferation was observed in foci of HBsAg-positive and –negative hepatocytes isolated by laser-microdissection. Heterogeneous expression of cellular proteins was detected using IMS in hepatocytes with apparently normal histology. These results indicate that clonal proliferation of hepatocytes with survival advantage does occur in the hepatocyte population during chronic HBV infection and can be detected before histological changes are evident in the hepatocytes of patients with both early- and late-stage disease. Consistent with our hypothesis, larger hepatocyte clones were associated with disease progression. The cause of the clonal proliferation remains unknown. Contrary to our hypothesis, loss of HBsAg expression was not associated with increased clonal proliferation, suggesting that escape from HBsAg-specific immune attack is not a survival advantage. While not investigated in this thesis, the loss of expression of other HBV antigens may provide a survival advantage. Heterogeneous cellular protein expression suggests that hepatocyte phenotype has been altered in some hepatocytes. However, we could not show using invPCR approaches that the foci of hepatocytes with altered cellular protein expression were clonal. In conclusion, this research has provided groundwork in determining the relationship between the clonal proliferation of hepatocytes, altered hepatocyte phenotype and HBV-associated disease progression. Further studies into the molecular causes of clonal proliferation of hepatocytes with survival advantages could elucidate pathways of HBV-associated disease progression and novel ways to curb the evolution of the hepatocyte population to a less pathogenic state.
    12/2012, Degree: PhD in Sciences, Supervisor: Allison Jilbert

Bino John